Side Effects of Abilify: Childhood Diabetes and Compulsive Gambling in Adults
Abilify (aripiprazole) is one of the best selling drugs in the world, with 2013 sales estimated at more than $6 billion worldwide. It was approved by the FDA in 2002, for the treatment of a number of psychological problems, including schizophrenia, bipolar disorder, depression and autism in adults and children.
The lawyers at Saiontz & Kirk, P.A. are reviewing potential lawsuits as a result of the manufacturers failure to adequately warn about the two different potential side effects of Abilify, which it appears that the drug makers failed to adequately warn about on the drug label, including:
To review a potential claim for yourself, a friend or family member, request a free consultation and claim evaluation.
Abilify Gambling Side Effects
Abilify (aripiprazole) is part of a class of drugs known as partial dopamine receptor agonists, which works by affecting the activity of some key brain chemicals.
While it has been known for years that similar dopamine receptor agonists may carry an increased risk of impulse control side effects, it appears that Otsuka Pharmaceuticals failed to adequately research the link between Abilify and gambling.
Many users of Abilify have reported side effects such as gambling addictions, unusual sexual behavior, compulsive shopping and other impulsive activities that can have a devastating impact on an individuals family, employment, financial position and overall quality of life.
Potential claims are being reviewed for situations where gambling side effects of Abilify may have resulted in:
- Substantial Debt or Lost Savings
- Loss of Employment
- Divorce or Family Problems
- Severe Reputation and Quality of Life Damage
Abilify Diabetes Side Effects for Children
Although it has been known that side effects of Abilify side effects of Abilify and other similar atypical antipsychotics may increase the risk of weight gain and diabetes, it appears that inadequate warnings were provided about the potentially serious and life-long risks children may face from using the medication.
Otsuka Pharmaceuticals has aggressively promoted Abilify and encouraged the widespread use of the medication, especially among children.
Lawsuits allege that the drug makers should have provided clearer warnings about the serious and potentially life-altering impact Abilify side effects may have on children, as the medication may increase the risk more than 7% above normal when the medication is used at the average dose.
As a result of diabetes from Abilify, children may be left with medical problems that severely impact their overall health and qualify of life.
Managing type 2 diabetes requires frequent testing of blood glucose levels, adherence to a strict diabetic diet and may result in the need for the children to take medications to control diabetes for years and possibly for the rest of their lives.